Intervention
Testosterone therapy consisted of administration of intramuscular testosterone undecanoate, 1000 mg, at weeks 0 and 6, or transdermal testosterone, 1% (12.5 mg/actuation), gel 4 pump actuations daily. Participants were able to choose between these formulations as per standard care.